Abivax

0 followers


Abivax SA is a clinical-stage, publicly traded biotechnology company harnessing the immune system to develop novel treatments against inflammatory diseases, viral diseases and cancer.

Industries

Headquarters

Paris, France

Employees

11-50

Links


Org chart

Marc De Garidel
Chief Executive Officer
Collapse
Ida Hatoum
Chief People Officer
Didier Scherrer
Chief Scientific Officer
Didier Blondel
EVP, CFO & Board Secretary
Pierre Courteille
Chief Commercial Officer & VP of Business Development
Jérôme Denis
VP of Process Development & Manufacturing
Ana Sharma
Vice President, Global Head, Quality Assurance And Data Privacy
Mary Mantock
SVP Regulatory Affairs
Nadege Briancon-Eris
Senior Vice President, Program Management
Christine Cook
Executive Business Partner | Head Of Administration US
Chris Rabbat
Vice President And Head Of Medical Affairs
Julien Santo
Translational Research Director
Fabio Cataldi
EVP And Chief Medical Officer
David Zhang
Chief Strategy Officer
Marcus Wilkes
Head Of Global Market Access

Board & advisors

Ian McGowan
Chairman of the Scientific Advisory Board
Kinam Hong
Director
Corinna Zur Bonsen-Thomas
Member Board Of Directors, Interim Chairman 08/2022 - 05/2023,
Troy Ignelzi
Director
June Lee
Director
Christian Bréchot
Scientific Advisor
Christoph Huber
Scientific Advisor
Jürgen Rockstroh
Scientific Advisor
Lawrence R. Stanberry
Scientific Advisor
Claude Bertrand
Scientific Advisor
Christian Trépo
Scientific Advisor
Luc Teyton
Scientific Advisor